Form D · Biotechnology
Xdynia LLC
Charlottesville, VA · CIK 0001573324
Offering snapshot reported Mar 29, 2013 · SEC filing
- Reported sold
- $213K Indefinite offering
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 15, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 29, 2013 | Initial | $212,500 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-194216
Source: Form D, filed Mar 29, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Lloyd Gray | Executive |
| Andrew J. Krouse | Executive |
| Timothy Macdonald | Executive |
| Yuri Maricich | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
600 East Water Street, Suite F
Charlottesville, VA, 22902
Charlottesville, VA, 22902